Proton pump inhibitors and antibiotics increase mortality risk, while statins, renin-angiotensin system inhibitors.
Vous n'êtes pas connecté
Researchers have found that certain concomitant medications are associated with better or worse survival outcomes in patients with locally advanced or
Proton pump inhibitors and antibiotics increase mortality risk, while statins, renin-angiotensin system inhibitors.
KUALA LUMPUR: A recent study on kidney disease found that nearly half of patients with advanced chronic kidney disease (CKD) in the country lost their...
A new personalized cancer vaccine has shown encouraging results in preventing the return of kidney cancer after surgery. Researchers at Dana-Farber...
Heart transplants are complex, costly, and risky—but for patients with heart failure, they are often the only option for survival. Now,...
A new study has found that a common type of cancer treatment, called immune checkpoint inhibitors (ICIs), may not be very effective for patients who...
Eating yogurt regularly could help reduce the risk of a certain type of colorectal cancer. Researchers found that people who consumed yogurt with live...
Many people take medications to manage common health conditions, but some drugs may have unexpected side effects. A recent study from the University...
A new Colorado State University study of the interior U.S. West has found that tree ranges are generally contracting in response to climate change...
A common group of drugs used to treat type 2 diabetes and help with weight loss may also benefit people with kidney disease, according to researchers...
Cancer treatment has helped more children than ever survive acute lymphoblastic leukemia (ALL), the most common type of childhood cancer. Thanks...